Investopedia: Hi-Tech Pharmacal An Under-Followed Name Worth Following
Due to the seemingly insatiable appetites of companies like Teva (NYSE:TEVA), Mylan (Nasdaq:MYL) and Watson (NYSE:WPI),
there aren't nearly as many independent publicly-traded generic drug
companies as there used to be. While scarcity value alone is not a good
argument for considering Hi-Tech Pharmacal (Nasdaq:HITK),
this company's focus on higher-barrier products and over-the-counter
(OTC) cold and cough business, coupled with little sell-side support,
could make it a potential hidden gem at some point.